DEG analysis was conducted for AML-ASXL1 bone marrow (n = 26), and AML-ASXL1 blood samples from TCGA (n = 6), as well as tissue-matched healthy controls of blood from the GTEx portal (n = 60), and bone marrow samples from publicly available dataset GSE120444 (n = 8) samples. Here, ASXL1 is linked to acute myeloid leukemia.